Hecht Peter M
Transaction: 07/16/2026
SELL
Change
-351,037
Price
Not reported
Filing
07/20/2026
Type
SELL
Cyclerion Therapeutics, Inc.
CYCN • Biotechnology
Extraordinary move
CYCN-85.46%
vs. previous close $23.52
$3.42
▼ -20.10 (-85.46%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$14.54M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 5.15Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:21 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.42
Change-85.46%
Shares Out4.25M
Market Cap$14.54M
Enterprise Value$13.15M
52W Range1.03 - 8.48
Beta1.75
P/E-2.94
P/S7.65
P/B2.86
P/FCF-3.22
EV/Sales6.92
Price$3.42
Change-85.46%
Shares Out4.25M
Market Cap$14.54M
Enterprise Value$13.15M
52W Range1.03 - 8.48
Beta1.75
P/E-2.94
P/S7.65
P/B2.86
P/FCF-3.22
EV/Sales6.92
EV/EBITDA-1.94
EV/FCF-2.91
Earnings Yield-34.06%
FCF Yield-31.07%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-2.40%
Profit Margin-170.11%
Debt/Eq0.00
Current Ratio5.15
Quick Ratio5.15
Volume39.95K
Avg Volume34.72K
EPS Surprise16.44
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 5.15Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-20
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 2 high-volume insider sells detected
Hecht Peter M
Transaction: 07/16/2026
BUY
Change
+351,037
Price
$8.68
Filing
07/20/2026
Type
BUY
CHICKO RHONDA M.
Transaction: 08/07/2025
BUY
Change
+25,000
Price
$2.35
Filing
08/11/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hecht Peter M | SELL | -351,037 | Not reported | 07/16/2026 | 07/20/2026 |
| Hecht Peter M | BUY | +351,037 | $8.68 | 07/16/2026 | 07/20/2026 |
| CHICKO RHONDA M. | BUY | +25,000 | $2.35 | 08/07/2025 | 08/11/2025 |
| Higgins Michael J | BUY | +9,090 | $2.75 | 03/25/2025 | 03/27/2025 |
| Hecht Peter M | BUY | +181,818 | $2.75 | 03/25/2025 | 03/27/2025 |
| Slate Path Capital LP | SELL | -357,880 | $1.55 | 11/21/2024 | 11/25/2024 |
| Graul Regina Margaret | BUY | +55,849 | $3.30 | 08/05/2024 | 08/07/2024 |
| CHICKO RHONDA M. | SELL | 0 | Not reported | 03/04/2024 | 03/11/2024 |
| Graul Regina Margaret | BUY | +50,000 | Not reported | 01/01/2024 | 01/26/2024 |
| Hecht Peter M | BUY | +15,000 | Not reported | 01/01/2024 | 01/26/2024 |
| Katabi Dina | SELL | 0 | Not reported | 11/30/2023 | 12/11/2023 |
| Graul Regina Margaret | SELL | 0 | Not reported | 12/01/2023 | 12/07/2023 |
| Higgins Michael J | SELL | 0 | Not reported | 11/30/2023 | 12/07/2023 |
| Hecht Peter M | BUY | +15,000 | Not reported | 12/01/2023 | 12/04/2023 |
| Graul Regina Margaret | SELL | 0 | Not reported | 12/01/2023 | 12/04/2023 |
| Hyman Steven | BUY | +20,000 | Not reported | 11/30/2023 | 12/04/2023 |
| DESOUZA ERROL B | BUY | +30,000 | Not reported | 11/30/2023 | 12/04/2023 |
| Hecht Peter M | BUY | +20,000 | Not reported | 11/30/2023 | 12/04/2023 |
| MCGUIRE TERRANCE | BUY | +5,000 | Not reported | 11/30/2023 | 12/04/2023 |
| MCGUIRE TERRANCE | SELL | -8 | $3.40 | 08/09/2023 | 08/11/2023 |